Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Increased by Root Financial Partners LLC

Root Financial Partners LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,630 shares of the medical equipment provider’s stock after buying an additional 121 shares during the quarter. Root Financial Partners LLC’s holdings in Intuitive Surgical were worth $1,895,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter valued at $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $591.39 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market cap of $210.64 billion, a price-to-earnings ratio of 92.26, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The company has a fifty day moving average price of $557.70 and a two-hundred day moving average price of $517.49.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.